Role of Dietary and Endogenous Antioxidants in Diabetes

Critical Reviews in Food Science and Nutrition

Volumn 54, Issue 12, 2014, Pages 1599-1616

  Marrazzo, Giuseppina ^a   Barbagallo, Ignazio ^a   Galvano, Fabio ^a   Malaguarnera, Michele ^a   Gazzolo, Diego ^b,c   Frigiola, Alessandro ^c   D'Orazio, Nicolantonio ^d   Li Volti, Giovanni ^a,c  

^a UNIVERSITY OF CATANIA   (Italy)

^b SS Antonio e Biagio   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Antioxidants; central nervous system; Diabetes; diet

Indexed keywords

FREE RADICALS; MEDICAL PROBLEMS; NEUROPHYSIOLOGY; NUTRITION;

CENTRAL NERVOUS SYSTEMS; HYPERGLYCAEMIA; INTRACELLULAR OXIDATIVE STRESS; MOLECULAR MECHANISM; NON-ENZYMATIC;

ANTIOXIDANTS;

ANTIOXIDANT;

ANIMAL; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; DIET; DISEASE MODEL; DRUG EFFECT; HUMAN; HYPERGLYCEMIA; METABOLISM; OXIDATIVE STRESS; REVIEW;

ANIMALS; ANTIOXIDANTS; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; DIET; DISEASE MODELS, ANIMAL; HUMANS; HYPERGLYCEMIA; OXIDATIVE STRESS;

EID: 84896810906     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2011.644874     Document Type: Review

References (180)

1. Abiko, T., Abiko, A., Clermont, A. C., Shoelson, B., Horio, N., Takahashi, J., Adamis, A. P., King, G. L. and Bursell, S. E. 2003. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: Role of oxidants and protein kinase-C activation. Diabetes, 52: 829 - 837.
2. Abraham, N. G., Kushida, T., McClung, J., Weiss, M., Quan, S., Lafaro, R., Darzynkiewicz, Z. and Wolin, M. 2003. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res., 93: 507 - 514.
3. Affolter, V., Boujon, P., Bestetti, G. and Rossi, G. L. 1986. Hypothalamic and cortical neurons of normotensive and spontaneously hypertensive rats are differently affected by streptozotocin diabetes. Acta Neuropathol., 70: 135 - 141.
4. Alam, T. A., Seifalian, A. M. and Baker, D. 2005. A review of methods currently used for assessment of in vivo endothelial function. Eur. J. Vasc. Endovasc. Surg., 29: 269 - 276.
5. Ali, T. K. and El-Remessy, A. B. 2009. Diabetic retinopathy: Current management and experimental therapeutic targets. Pharmacotherapy, 29: 182 - 192.
6. Ammon, H. P. and Wahl, M. A. 1991. Pharmacology of Curcuma longa. Planta Med., 57: 1 - 7.
7. Anderson, R. A., Roussel, A. M., Zouari, N., Mahjoub, S., Matheau, J. M. and Kerkeni, A. 2001. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J. Am. Coll. Nutr., 20: 212 - 218.
8. Anetor, J. I., Senjobi, A., Ajose, O. A. and Agbedana, E. O. 2002. Decreased serum magnesium and zinc levels: Atherogenic implications in type-2 diabetes mellitus in Nigerians. Nutr. Health, 16: 291 - 300.
9. Arieff, A. I. and Kleeman, C. R. 2000. Studies on mechanisms of cerebral edema in diabetic comas: Effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits (J. Clin. Invest. 52:571-583, 1973). J. Am. Soc. Nephrol., 11: 1776 - 1788.
10. Arun, N. and Nalini, N. 2002. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant. Foods Hum. Nutr., 57: 41 - 52.
11. Baek, K. J., Thiel, B. A., Lucas, S. and Stuehr, D. J. 1993. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J. Biol. Chem., 268: 21120 - 21129.
12. Barbosa, K. B., Bressan, J., Zulet, M. A. and Martinez Hernandez, J. A. 2008. Influence of dietary intake on plasma biomarkers of oxidative stress in humans. An. Sist. Sanit. Navar., 31: 259 - 280.
13. Beauquis, J., Roig, P., De Nicola, A. F. and Saravia, F. 2009. Neuronal plasticity and antidepressants in the diabetic brain. Ann. N. Y. Acad. Sci., 1153: 203 - 208.
14. Beckman, J. S. and Koppenol, W. H. 1996. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am. J. Physiol, 271: C1424 - C1437.
15. Benz, D., Cadet, P., Mantione, K., Zhu, W. and Stefano, G. 2002. Tonal nitric oxide and health: Anti-bacterial and -viral actions and implications for HIV. Med. Sci. Monit., 8: RA27 - RA31.
16. Bhagavan, H. N. and Chopra, R. K. 2006. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res., 40: 445 - 453.
17. Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Muller, M., Wahl, P., Ziegler, R. and Nawroth, P. P. 1997. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes, 46: 1481 - 1490.
18. Bongiovanni, G. A., Soria, E. A. and Eynard, A. R. 2007. Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. Food Chem. Toxicol., 45: 971 - 976.
19. Bonow, R. O. and Gheorghiade, M. 2004. The diabetes epidemic: A national and global crisis. Am. J. Med., 116 (Suppl 5A): 2S - 10S.
20. Brands, A. M., Biessels, G. J., de Haan, E. H., Kappelle, L. J. and Kessels, R. P. 2005. The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care, 28: 726 - 735.
21. Brigelius-Flohe, R. and Traber, M. G. 1999. Vitamin E: Function and metabolism. FASEB J., 13: 1145 - 1155.
22. Brodsky, S. V., Gao, S., Li, H. and Goligorsky, M. S. 2002. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am. J. Physiol Heart Circ. Physiol, 283: H2130 - H2139.
23. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813 - 820.
24. Brownlee, M. 2005. The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54: 1615 - 1625.
25. Caballero, A. E., Arora, S., Saouaf, R., Lim, S. C., Smakowski, P., Park, J. Y., King, G. L., LoGerfo, F. W., Horton, E. S. and Veves, A. 1999. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes, 48: 1856 - 1862.
26. Cai, F., Li, C., Wu, J., Min, Q., Ouyang, C., Zheng, M., Ma, S., Yu, W. and Lin, F. 2007. Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3′-gallate in the rats exposed to cerebral ischemia-reperfusion. Folia Biol. (Praha), 53: 164 - 172.
27. Cai, Q., Rahn, R. O. and Zhang, R. 1997. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett., 119: 99 - 107.
28. Charonis, A. S., Reger, L. A., Dege, J. E., Kouzi-Koliakos, K., Furcht, L. T., Wohlhueter, R. M. and Tsilibary, E. C. 1990. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes, 39: 807 - 814.
29. Cho, J. W., Lee, K. S. and Kim, C. W. 2007. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int. J. Mol. Med., 19: 469 - 474.
30. Clarke, J. A., Daly, M. B., Marshall, J. M., Ead, H. W. and Hennessy, E. M. 2000. Quantitative studies of the vasculature of the carotid body in the chronically hypoxic rat. Braz. J. Med. Biol. Res., 33: 331 - 340.
31. Collins, T. 1993. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest., 68: 499 - 508.
32. Cook, D. G., Leverenz, J. B., McMillan, P. J., Kulstad, J. J., Ericksen, S., Roth, R. A., Schellenberg, G. D., Jin, L. W., Kovacina, K. S. and Craft, S. 2003. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am. J. Pathol., 162: 313 - 319.
33. Cosentino, F., Hishikawa, K., Katusic, Z. S. and Luscher, T. F. 1997. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation, 96: 25 - 28.
34. Crane, F. L. 2001. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr., 20: 591 - 598.
35. Cross, A. R. and Jones, O. T. 1991. Enzymic mechanisms of superoxide production. Biochim. Biophys. Acta, 1057: 281 - 298.
36. Dairam, A., Limson, J. L., Watkins, G. M., Antunes, E. and Daya, S. 2007. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J. Agric. Food Chem., 55: 1039 - 1044.
37. Day, A. J., Mellon, F., Barron, D., Sarrazin, G., Morgan, M. R. and Williamson, G. 2001. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin. Free Radic. Res., 35: 941 - 952.
38. de la Monte, S. M. and Wands, J. R. 2005. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease. J. Alzheimers. Dis., 7: 45 - 61.
39. Doi, K., Sawada, F., Toda, G., Yamachika, S., Seto, S., Urata, Y., Ihara, Y., Sakata, N., Taniguchi, N., Kondo, T. and Yano, K. 2001. Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats. Free Radic. Res., 34: 251 - 261.
40. Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C. and Brownlee, M. 2001. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest, 108: 1341 - 1348.
41. Du, X. L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J. and Brownlee, M. 2000. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U. S. A., 97: 12222 - 12226.
42. Elchuri, S., Oberley, T. D., Qi, W., Eisenstein, R. S., Jackson, R. L., Van, R. H., Epstein, C. J. and Huang, T. T. 2005. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene, 24: 367 - 380.
43. Eliasson, M. J., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z. Q., Dawson, T. M., Snyder, S. H. and Dawson, V. L. 1997. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med., 3: 1089 - 1095.
44. Ewy, G. A. 1999. Antioxidant therapy for coronary artery disease: Don't paint the walls without treating the termites!. Arch. Intern. Med., 159: 1279 - 1280.
45. Fan, E., Zhang, L., Jiang, S. and Bai, Y. 2008. Beneficial effects of resveratrol on atherosclerosis. J. Med. Food, 11: 610 - 614.
46. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J. and Guenette, S. 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U. S. A, 100: 4162 - 4167.
47. Faure, P., Benhamou, P. Y., Perard, A., Halimi, S. and Roussel, A. M. 1995. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: Effects of an oral zinc supplementation. Eur. J. Clin. Nutr., 49: 282 - 288.
48. Foresti, R. and Motterlini, R. 1999. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic. Res., 31: 459 - 475.
49. Frolich, L., Blum-Degen, D., Bernstein, H. G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Turk, A., Hoyer, S., Zochling, R., Boissl, K. W., Jellinger, K. and Riederer, P. 1998. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm., 105: 423 - 438.
50. Gabbay, K. H., Merola, L. O. and Field, R. A. 1966. Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes. Science, 151: 209 - 210.
51. Galvano, F., La, F. L., Vitaglione, P., Fogliano, V., Vanella, L. and Felgines, C. 2007. Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides. Ann. Ist. Super. Sanita, 43: 382 - 393.
52. Garcia, S. F., Virag, L., Jagtap, P., Szabo, E., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G., Salzman, A. L., Southan, G. J. and Szabo, C. 2001. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation. Nat. Med., 7: 108 - 113.
53. Gasparini, L. and Xu, H. 2003. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci., 26: 404 - 406.
54. Golden, S. H., Folsom, A. R., Coresh, J., Sharrett, A. R., Szklo, M. and Brancati, F. 2002. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: The atherosclerosis risk in communities study. Diabetes, 51: 3069 - 3076.
55. Goldfine, A. B., Beckman, J. A., Betensky, R. A., Devlin, H., Hurley, S., Varo, N., Schonbeck, U., Patti, M. E. and Creager, M. A. 2006. Family history of diabetes is a major determinant of endothelial function. J. Am. Coll. Cardiol., 47: 2456 - 2461.
56. Gould, C. M. and Newton, A. C. 2008. The life and death of protein kinase C. Curr. Drug Targets., 9: 614 - 625.
57. Greene, E. L., Nelson, B. A., Robinson, K. A. and Buse, M. G. 2001. alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation. Metabolism, 50: 1063 - 1069.
58. Guo, H., Ling, W., Wang, Q., Liu, C., Hu, Y. and Xia, M. 2008. Cyanidin 3-glucoside protects 3T3-L1 adipocytes against. Biochem. Pharmacol., 75: 1393 - 1401.
59. Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R. and Channon, K. M. 2002. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation, 105: 1656 - 1662.
60. Ha, H. C., Hester, L. D. and Snyder, S. H. 2002. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. U. S. A., 99: 3270 - 3275.
61. Haak, E., Usadel, K. H., Kusterer, K., Amini, P., Frommeyer, R., Tritschler, H. J. and Haak, T. 2000. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp. Clin. Endocrinol. Diabetes, 108: 168 - 174.
62. Haglund, B., Ryckenberg, K., Selinus, O. and Dahlquist, G. 1996. Evidence of a relationship between childhood-onset type I diabetes and low groundwater concentration of zinc. Diabetes Care, 19: 873 - 875.
63. Hammes, H. P., Martin, S., Federlin, K., Geisen, K. and Brownlee, M. 1991. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. U. S. A, 88: 11555 - 11558.
64. Hart, G. W. 1997. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem., 66: 315 - 335.
65. Hatzinikolaou, P., Brecher, P. and Gavras, H. 1981. Chronic hypertension increases tyrosine transport across the blood-brain barrier in the rat. Life Sci., 29: 1657 - 1660.
66. Heilig, C. W., Concepcion, L. A., Riser, B. L., Freytag, S. O., Zhu, M. and Cortes, P. 1995. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J. Clin. Invest, 96: 1802 - 1814.
67. Higdon, J. V. and Frei, B. 2003. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev. Food Sci. Nutr., 43: 89 - 143.
68. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D. G., Forstermann, U. and Munzel, T. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res., 88: E14 - E22.
69. Hofmann, M. A., Schiekofer, S., Kanitz, M., Klevesath, M. S., Joswig, M., Lee, V., Morcos, M., Tritschler, H., Ziegler, R., Wahl, P., Bierhaus, A. and Nawroth, P. P. 1998. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care, 21: 1310 - 1316.
70. Hoyer, S. 1998. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural Transm., 105: 415 - 422.
71. Hua, H., Munk, S., Goldberg, H., Fantus, I. G. and Whiteside, C. I. 2003. High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J. Biol. Chem., 278: 33951 - 33962.
72. Idris, I., Gray, S. and Donnelly, R. 2001. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia, 44: 659 - 673.
73. Ihara, Y., Toyokuni, S., Uchida, K., Odaka, H., Tanaka, T., Ikeda, H., Hiai, H., Seino, Y. and Yamada, Y. 1999. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes, 48: 927 - 932.
74. Inoguchi, T., Sonta, T., Tsubouchi, H., Etoh, T., Kakimoto, M., Sonoda, N., Sato, N., Sekiguchi, N., Kobayashi, K., Sumimoto, H., Utsumi, H. and Nawata, H. 2003. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of vascular NAD(P)H oxidase. J. Am. Soc. Nephrol., 14: S227 - S232.
75. Jakobsen, J., Sidenius, P., Gundersen, H. J. and Osterby, R. 1987. Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats. Diabetes, 36: 597 - 601.
76. Johnson, L. J., Meacham, S. L. and Kruskall, L. J. 2003. The antioxidants-vitamin C,vitamin E, selenium, and carotenoids. J. Agromed., 9: 65 - 82.
77. Kaiser, N., Sasson, S., Feener, E. P., Boukobza-Vardi, N., Higashi, S., Moller, D. E., Davidheiser, S., Przybylski, R. J. and King, G. L. 1993. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes, 42: 80 - 89.
78. Kajanachumpol, S., Komindr, S. and Mahaisiriyodom, A. 1997. Plasma lipid peroxide and antioxidant levels in diabetic patients. J. Med. Assoc. Thai., 80: 372 - 377.
79. Kajanachumpol, S., Srisurapanon, S., Supanit, I., Roongpisuthipong, C. and Apibal, S. 1995. Effect of zinc supplementation on zinc status, copper status and cellular immunity in elderly patients with diabetes mellitus. J. Med. Assoc. Thai., 78: 344 - 349.
80. Kalmijn, S., Feskens, E. J., Launer, L. J., Stijnen, T. and Kromhout, D. 1995. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia, 38: 1096 - 1102.
81. Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J. and Launer, L. J. 2000. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler. Thromb. Vasc. Biol., 20: 2255 - 2260.
82. Kamoshima, W., Kitamura, Y., Nomura, Y. and Taniguchi, T. 1997. Possible involvement of ADP-ribosylation of particular enzymes in cell death induced by nitric oxide-donors in human neuroblastoma cells. Neurochem. Int., 30: 305 - 311.
83. Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y. and Hori, M. 1999. Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic beta-cells against glucose toxicity. Diabetes, 48: 2398 - 2406.
84. Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H. L., Beal, M. F. and Gibson, G. E. 2009. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int., 54: 111 - 118.
85. Kechrid, Z., Bouzerna, N. and Zio, M. S. 2001. Effect of low zinc diet on (65)Zn turnover in non-insulin dependent diabetic mice. Diabetes Metab, 27: 580 - 583.
86. Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M. and Horwitz, R. I. 2002. Insulin resistance and risk for stroke. Neurology, 59: 809 - 815.
87. Kim, J. D., Byun, H. G., Kim, D. J., Ham, Y. K., Jung, W. S. and Yoon, C. O. 2006. A simple taste analyzing system design for visual and quantitative analysis of different tastes using multi-array chemical sensors and pattern recognition techniques. Talanta, 70: 546 - 555.
88. Kim, J. M., Araki, S., Kim, D. J., Park, C. B., Takasuka, N., Baba-Toriyama, H., Ota, T., Nir, Z., Khachik, F., Shimidzu, N., Tanaka, Y., Osawa, T., Uraji, T., Murakoshi, M., Nishino, H. and Tsuda, H. 1998. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis, 19: 81 - 85.
89. Klatzo, I. 1983. Disturbances of the blood-brain barrier in cerebrovascular disorders. Acta Neuropathol. Suppl, 8: 81 - 88.
90. Klotz, L. O. and Sies, H. 2003. Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol. Lett., 140-141: 125 - 132.
91. Kolm-Litty, V., Sauer, U., Nerlich, A., Lehmann, R. and Schleicher, E. D. 1998. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J. Clin. Invest, 101: 160 - 169.
92. Korshunov, S. S., Skulachev, V. P. and Starkov, A. A. 1997. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett., 416: 15 - 18.
93. Kowluru, R. A. and Kennedy, A. 2001. Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert. Opin. Investig. Drugs, 10: 1665 - 1676.
94. Koya, D., Lee, I. K., Ishii, H., Kanoh, H. and King, G. L. 1997. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol., 8: 426 - 435.
95. Kuusisto, J., Koivisto, K., Mykkanen, L., Helkala, E. L., Vanhanen, M., Hanninen, T., Kervinen, K., Kesaniemi, Y. A., Riekkinen, P. J. and Laakso, M. 1997. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ, 315: 1045 - 1049.
96. Kuusisto, J., Koivisto, K., Mykkanen, L., Helkala, E. L., Vanhanen, M., Hanninen, T., Pyorala, K., Riekkinen, P. and Laakso, M. 1993. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension, 22: 771 - 779.
97. Le, R. D. and Zick, Y. 2001. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care, 24: 588 - 597.
98. Lee, A. Y. and Chung, S. S. 1999. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J., 13: 23 - 30.
99. Leung, L. K., Su, Y., Chen, R., Zhang, Z., Huang, Y. and Chen, Z. Y. 2001. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J. Nutr., 131: 2248 - 2251.
100. Li, N. and Karin, M. 1999. Is NF-kappaB the sensor of oxidative stress?. FASEB J., 13: 1137 - 1143.
101. Li, Y., Huang, T. T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., Wallace, D. C. and Epstein, C. J. 1995. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet., 11: 376 - 381.
102. Li, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., Li, J., Stitt, A., He, C., Banerjee, D. and Vlassara, H. 1996. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl. Acad. Sci. U. S. A, 93: 11047 - 11052.
103. Liao, Y. J., Ueno, M., Nakagawa, T., Huang, C., Kanenishi, K., Onodera, M. and Sakamoto, H. 2005. Oxidative damage in cerebral vessels of diabetic db/db mice. Diabetes Metab Res. Rev., 21: 554 - 559.
104. Lim, S. C., Tan, H. H., Goh, S. K., Subramaniam, T., Sum, C. F., Tan, I. K., Lee, B. L. and Ong, C. N. 2006. Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q(10). Diabet. Med., 23: 1344 - 1349.
105. Ling, Y., Morgan, K. and Kalsheker, N. 2003. Amyloid precursor protein (APP) and the biology of proteolytic processing: Relevance to Alzheimer's disease. Int. J. Biochem. Cell Biol., 35: 1505 - 1535.
106. Loke, W. M., Proudfoot, J. M., Hodgson, J. M., McKinley, A. J., Hime, N., Magat, M., Stocker, R. and Croft, K. D. 2010. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol., 30: 749 - 757.
107. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med., 338: 436 - 445.
108. Maines, M. D. 1997. The heme oxygenase system: A regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol., 37: 517 - 554.
109. Masuda, T., Hidaka, K., Shinohara, A., Maekawa, T., Takeda, Y. and Yamaguchi, H. 1999. Chemical studies on antioxidant mechanism of curcuminoid: Analysis of radical reaction products from curcumin. J. Agric. Food Chem., 47: 71 - 77.
110. Mayhan, W. G. 1993. Cerebral circulation during diabetes mellitus. Pharmacol. Ther., 57: 377 - 391.
111. McCuskey, P. A. and McCuskey, R. S. 1984. In vivo and electron microscopic study of the development of cerebral diabetic microangiography. Microcirc. Endoth. Lym, 1: 221 - 244.
112. McLellan, A. C., Thornalley, P. J., Benn, J. and Sonksen, P. H. 1994. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond), 87: 21 - 29.
113. Meier, M. and King, G. L. 2000. Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc. Med., 5: 173 - 185.
114. Meier, M., Menne, J. and Haller, H. 2009. Targeting the protein kinase C family in the diabetic kidney: Lessons from analysis of mutant mice. Diabetologia, 52: 765 - 775.
115. Meigs, J. B. 2000. Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am. J. Epidemiol., 152: 908 - 911.
116. Moncada, S., Palmer, R. M. and Higgs, E. A. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43: 109 - 142.
117. Montero, A., Munger, K. A., Khan, R. Z., Valdivielso, J. M., Morrow, J. D., Guasch, A., Ziyadeh, F. N. and Badr, K. F. 2000. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int., 58: 1963 - 1972.
118. Mooradian, A. D. 2003. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch. Intern. Med., 163: 33 - 40.
119. Motterlini, R., Gonzales, A., Foresti, R., Clark, J. E., Green, C. J. and Winslow, R. M. 1998. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ. Res., 83: 568 - 577.
120. Mueller, S. M. and Luft, F. C. 1982. The blood-brain barrier in renovascular hypertension. Stroke, 13: 229 - 234.
121. Mukhtar, H. and Ahmad, N. 2000. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr., 71: 1698S - 1702S.
122. Muller, F. L., Song, W., Liu, Y., Chaudhuri, A., Pieke-Dahl, S., Strong, R., Huang, T. T., Epstein, C. J., Roberts, L. J., Csete, M., Faulkner, J. A. and Van, R. H. 2006. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med., 40: 1993 - 2004.
123. Muthukumaran, S., Sudheer, A. R., Menon, V. P. and Nalini, N. 2008. Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicology, 243: 207 - 215.
124. Nathan, C. and Xie, Q. W. 1994. Nitric oxide synthases: Roles, tolls, and controls. Cell, 78: 915 - 918.
125. Neve, J. 1996. Selenium as a risk factor for cardiovascular diseases. J. Cardiovasc. Risk, 3: 42 - 47.
126. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I. and Brownlee, M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404: 787 - 790.
127. Packer, L., Kraemer, K. and Rimbach, G. 2001. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 17: 888 - 895.
128. Palsamy, P. and Subramanian, S. 2008. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed. Pharmacother., 62: 598 - 605.
129. Park, K. S., Kim, J. H., Kim, M. S., Kim, J. M., Kim, S. K., Choi, J. Y., Chung, M. H., Han, B., Kim, S. Y. and Lee, H. K. 2001. Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes, 50: 2837 - 2841.
130. Parker, P. J. and Murray-Rust, J. 2004. PKC at a glance. J. Cell Sci., 117: 131 - 132.
131. Paulke, A., Schubert-Zsilavecz, M. and Wurglics, M. 2006. Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 832: 109 - 113.
132. Playford, D. A., Watts, G. F., Croft, K. D. and Burke, V. 2003. Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes. Atherosclerosis, 168: 169 - 179.
133. Rajakrishnan, V., Viswanathan, P., Rajasekharan, K. N. and Menon, V. P. 1999. Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother. Res., 13: 571 - 574.
134. Riccioni, G., Bucciarelli, T., Mancini, B., Di, I. C., Capra, V. and D'Orazio, N. 2007. The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert. Opin. Investig. Drugs, 16: 25 - 32.
135. Riccioni, G., D'Orazio, N., Palumbo, N., Bucciarelli, V., Ilio, E., Bazzano, L. A. and Bucciarelli, T. 2009. Relationship between plasma antioxidant concentrations and carotid intima-media thickness: The Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study. Eur. J. Cardiovasc. Prev. Rehabil., 16: 351 - 357.
136. Rosca, M. G., Mustata, T. G., Kinter, M. T., Ozdemir, A. M., Kern, T. S., Szweda, L. I., Brownlee, M., Monnier, V. M. and Weiss, M. F. 2005. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol Renal Physiol, 289: F420 - F430.
137. Roussel, A. M., Kerkeni, A., Zouari, N., Mahjoub, S., Matheau, J. M. and Anderson, R. A. 2003. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J. Am. Coll. Nutr., 22: 316 - 321.
138. Ruhe, R. C. and McDonald, R. B. 2001. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J. Am. Coll. Nutr., 20: 363S - 369S.
139. Sage, J. I., Van Uitert, R. L. and Duffy, T. E. 1984. Early changes in blood brain barrier permeability to small molecules after transient cerebral ischemia. Stroke, 15: 46 - 50.
140. Sasaki, R., Nishimura, N., Hoshino, H., Isa, Y., Kadowaki, M., Ichi, T., Tanaka, A., Nishiumi, S., Fukuda, I., Ashida, H., Horio, F. and Tsuda, T. 2007. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol., 74: 1619 - 1627.
141. Scazzocchio, B., Vari, R., Filesi, C., D'Archivio, M., Santangelo, C., Giovannini, C., Iacovelli, A., Silecchia, G., Li, V. G., Galvano, F. and Masella, R. 2011. Cyanidin-3-O-{beta}-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPAR{gamma} activity in human omental adipocytes. Diabetes, 60: 2234 - 2244.
142. Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Kustermann, E., Arndt, S., Jacobs, A. H., Krone, W., Kahn, C. R. and Bruning, J. C. 2004. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A, 101: 3100 - 3105.
143. Sentman, M. L., Granstrom, M., Jakobson, H., Reaume, A., Basu, S. and Marklund, S. L. 2006. Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase. J. Biol. Chem., 281: 6904 - 6909.
144. Sharma, S., Chopra, K. and Kulkarni, S. K. 2007. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide and TNF-alpha. Phytother. Res., 21: 278 - 283.
145. Sies, H. 1997. Oxidative stress: Oxidants and antioxidants. Exp. Physiol, 82: 291 - 295.
146. Sohal, R. S. 2004. Coenzyme Q and vitamin E interactions. Methods Enzymol., 378: 146 - 151.
147. Spitaler, M. M. and Graier, W. F. 2002. Vascular targets of redox signalling in diabetes mellitus. Diabetologia, 45: 476 - 494.
148. Srimal, R. C. and Dhawan, B. N. 1973. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol., 25: 447 - 452.
149. Srivivasan, A., Menon, V. P., Periaswamy, V. and Rajasekaran, K. N. 2003. Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J. Pharm. Pharm. Sci., 6: 327 - 333.
150. Stanner, S. A., Hughes, J., Kelly, C. N. and Buttriss, J. 2004. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr., 7: 407 - 422.
151. Stewart, R. and Liolitsa, D. 1999. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med., 16: 93 - 112.
152. Strachan, M. W., Deary, I. J., Ewing, F. M. and Frier, B. M. 1997. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care, 20: 438 - 445.
153. Stranahan, A. M., Arumugam, T. V., Cutler, R. G., Lee, K., Egan, J. M. and Mattson, M. P. 2008. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci., 11: 309 - 317.
154. Studer, R. K., Craven, P. A. and DeRubertis, F. R. 1997. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism., 46: 918 - 925.
155. Subramanian, M., Sreejayan, Rao, M. N., Devasagayam, T. P. and Singh, B. B. 1994. Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat. Res., 311: 249 - 255.
156. Sui, Z., Salto, R., Li, J., Craik, C. and Ortiz de Montellano, P. R. 1993. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg. Med. Chem., 1: 415 - 422.
157. Terres-Martos, C., Navarro-Alarcon, M., Martin-Lagos, F., Lopez, G., Perez-Valero, V. and Lopez-Martinez, M. C. 1998. Serum zinc and copper concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes. J. Trace Elem. Med. Biol., 12: 44 - 49.
158. Ting, H. H., Timimi, F. K., Boles, K. S., Creager, S. J., Ganz, P. and Creager, M. A. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest, 97: 22 - 28.
159. Trachtman, H., Futterweit, S. and Bienkowski, R. S. 1993. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem. Biophys. Res. Commun., 191: 759 - 765.
160. Trumpower, B. L. 1990. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J. Biol. Chem., 265: 11409 - 11412.
161. Uchiyama, S. and Yamaguchi, M. 2003. Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate. Int. J. Mol. Med., 12: 949 - 954.
162. Unnikrishnan, M. K. and Rao, M. N. 1995. Curcumin inhibits nitrogen dioxide induced oxidation of hemoglobin. Mol. Cell Biochem., 146: 35 - 37.
163. Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A. and Pasagian, A. 1988. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science, 240: 1546 - 1548.
164. von, G. G., Zimmermann, T., Albrecht, S., Bachmann, L., Zwipp, H. and Saeger, H. D. 1999. Significance of selenium in regulation of inflammatory response by transcription factors in polytrauma patients. A clinical study. Med. Klin. (Munich), 94 (Suppl 3): 62 - 65.
165. Wako, Y., Suzuki, K., Goto, Y. and Kimura, S. 1986. Vitamin A transport in plasma of diabetic patients. Tohoku J. Exp. Med., 149: 133 - 143.
166. Wallace, D. C. 1992. Diseases of the mitochondrial DNA. Annu. Rev. Biochem., 61: 1175 - 1212.
167. Watson, G. S. and Craft, S. 2004. Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer's disease. Eur. J. Pharmacol., 490: 97 - 113.
168. Weekers, L. and Krzesinski, J. M. 2005. Diabetic nephropathy. Rev. Med. Liege, 60: 479 - 486.
169. Wells, L. and Hart, G. W. 2003. O-GlcNAc turns twenty: Functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett., 546: 154 - 158.
170. Widlansky, M. E., Gokce, N., Keaney, J. F. Jr. and Vita, J. A. 2003. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol., 42: 1149 - 1160.
171. Will, J. C. and Byers, T. 1996. Does diabetes mellitus increase the requirement for vitamin C?. Nutr. Rev., 54: 193 - 202.
172. Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E. M., Harris, T., Shorr, R. I., Tylavsky, F. A. and Newman, A. B. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA, 292: 2237 - 2242.
173. Yamaguchi, M. and Uchiyama, S. 2003. Preventive effect of zinc acexamate administration in streptozotocin-diabetic rats: Restoration of bone loss. Int. J. Mol. Med., 12: 755 - 761.
174. Yavuz, O., Cam, M., Bukan, N., Guven, A. and Silan, F. 2003. Protective effect of melatonin on beta-cell damage in streptozotocin-induced diabetes in rats. Acta Histochem., 105: 261 - 266.
175. Yerneni, K. K., Bai, W., Khan, B. V., Medford, R. M. and Natarajan, R. 1999. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes, 48: 855 - 864.
176. Zhao, B. L., Li, X. J., He, R. G., Cheng, S. J. and Xin, W. J. 1989. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys., 14: 175 - 185.
177. Zhao, H. X., Mold, M. D., Stenhouse, E. A., Bird, S. C., Wright, D. E., Demaine, A. G. and Millward, B. A. 2001. Drinking water composition and childhood-onset type 1 diabetes mellitus in Devon and Cornwall, England. Diabet. Med., 18: 709 - 717.
178. Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M. J. and Alkon, D. L. 1999. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem., 274: 34893 - 34902.
179. Zheng, Y., Li, X. K., Wang, Y. and Cai, L. 2008. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: Therapeutic effects by chelators. Hemoglobin, 32: 135 - 145.
180. Zou, M. H., Shi, C. and Cohen, R. A. 2002. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest, 109: 817 - 826.